Acasta Partners UK »

Viridian Therapeutics shares owned by Acasta Partners UK

Quarter-by-quarter ownership of Viridian Therapeutics shares owned by Acasta Partners UK from 13F filings

Historical chart of Acasta Partners UK investment in Viridian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viridian Therapeutics held by Acasta Partners UK consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viridian Therapeutics by Acasta Partners UK

Quarter filed Position value Share count Share price at filing
2026-09-30 $5.7M 5.0M 1.15

More positions owned by Acasta Partners UK

Alibaba Group Holding Cv Bond (Principal)
Lithium Argentina Cv Bond (Principal)
Jazz Investments I Cv Bond (Principal)
McEwen Cv Bond (Principal)
iShares iBoxx $ High Yield Corporate Bond ETF Ord (HYG)
Ramaco Resources Cv Bond (Principal)
Office Properties Income Trust Ord
Viridian Therapeutics Cv Bond (Principal)
Hudbay Minerals Ord (HBM)
Celcuity Cv Bond (Principal)
Celcuity Cv Bond (Principal)
Cameco Corporation Ord (CCJ)
Arrowhead Pharmaceuticals Cv Bond (Principal)
USA Rare Earth Class A (USAR)
Uranium Energy Corp. Ord (UEC)

View all positions for Acasta Partners UK

Top funds holding Viridian Therapeutics

Context Capital Management
Citadel Advisors
Polar Securities
Ubs Global Asset Management Americas
D. E. Shaw & Co
Linden Advisors
DeepCurrents Investment Group
Nuveen
Jane Street
Tenor Capital Management
Silverback Asset Management
BlackRock
Acasta Partners UK
Nicholas Investments Partners
CSS

View all funds holding Viridian Therapeutics